Antibody against the endothelin receptor subtype A, and uses thereof
US12084505B2 · kind B2 · utility
0Cited by
1References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 4, 2019 |
| Grant date | Sep 10, 2024 |
| Priority date | — |
| Expiry date | Jul 30, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to antibodies against the endothelin receptor subtype A, in particular monoclonal antibodies, fragments or derivatives thereof. The present invention also relates to the therapeutic or diagnostic use of this antibody or as a research tool in the field of cancers, in particular glioblastoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.